Post by Galderma

Aesthetic needs are evolving rapidly, driven by growing phenomena such as medication-driven weight loss and the long-overlooked skin changes that accompany menopause. New interim results from two investigator-initiated studies help bring greater scientific clarity to these two aesthetic needs. The studies underscore the value of regenerative treatment approaches, and provide insight into how treatment sequencing of Restylane® Skinboosters™ and Sculptra® may be optimized for patients experiencing menopause. Galderma proudly supported these studies as part of its long‑standing commitment to understanding patients’ evolving needs and helping healthcare professionals deliver the best solutions for optimal patient outcomes. Read more about the results: https://lnkd.in/dEYFVpw6 Always consult a healthcare professional for individualized treatment recommendations and to discuss important safety information and risks associated with the use of the products.